COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences

Shih-Lung Cheng; Ching-Hsiung Lin

doi:10.3390/diagnostics11071153

COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences

Diagnostics (Basel). 2021 Jun 24;11(7):1153. doi: 10.3390/diagnostics11071153.

Authors

Shih-Lung Cheng^{1

2}, Ching-Hsiung Lin^{3

4

5}

Affiliations

¹ Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei 22060, Taiwan.
² Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli District, Taoyuan 320315, Taiwan.
³ Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan.
⁴ Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 40227, Taiwan.
⁵ Department of Recreation and Holistic Wellness, MingDao University, Changhua 50006, Taiwan.

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease that is associated with significant morbidity and mortality, giving rise to an enormous social and economic burden. The Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) report is one of the most frequently used documents for managing COPD patients worldwide. A survey was conducted across country-level members of Asia-Pacific Society of Respiratory (APSR) for collecting an updated version of local COPD guidelines, which were implemented in each country. This is the first report to summarize the similarities and differences among the COPD guidelines across the Asia-Pacific region. The degree of airflow limitation, assessment of COPD severity, management, and pharmacologic therapy of stable COPD will be reviewed in this report.

Keywords: Asia; COPD guideline.